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Abstract
Prostaglandin F2a (PGF2a) released from the uterus causes alterations in luteal blood flow, reduces progesterone secretion, and induces
luteolysis in the bovine corpus luteum (CL). We have recently discovered that luteal blood flow in the periphery of the mature CL acutely
increases coincidently with pulsatile increases in a metabolite of PGF2a (PGFM). In this study, we characterized changes in regional luteal
blood flow together with regional alterations in endothelial nitric oxide synthase (eNOS) expression during spontaneous luteolysis and in
response to PGF2a. Smooth muscle actin-positive blood vessels larger than 20 mm were observed mainly in the periphery of mature CL.
PGF2a receptor was localized to luteal cells and large blood vessels in the periphery of mid-CL. PGF2a acutely stimulated eNOS expression
in the periphery but not in the center of mature CL. Injection of the NO donor S-nitroso-N-acetylpenicillamine into CL induced an acute
increase in luteal blood flow and shortened the estrous cycle. In contrast, injection of the NOS inhibitor L-NAME into CL completely
suppressed the acute increase in luteal blood flow induced by PGF2a and delayed the onset of luteolysis. In conclusion, PGF2a has a site-
restricted action depending on not only luteal phase but also the region in the CL. PGF2a stimulates eNOS expression, vasodilation of blood
vessels, and increased luteal blood flow in periphery of mature CL. Furthermore, the increased blood flow is mediated by NO, suggesting
that the acute increase in peripheral blood flow to CL is one of the first physiological indicators of NO action in response to PGF2a.
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Introduction
The corpus luteum (CL) is a transient organ established
by follicular cells following ovulation in many mam-
mals. The development of the CL is accompanied by
angiogenesis. In the bovine CL, vascular endothelial
cells account for up to 50% of the total cells whereas
steroidogenic cells account for w30% of the cells
(O’Shea et al. 1989, Lei et al. 1991). The formation of
a competent vascular system is essential for proper
development and function of the CL (Dickson et al.
2001). The steroidogenic cells, particularly large luteal
cells, produce and secrete a large amount of pro-
gesterone (P) during the estrous cycle (Rodgers et al.
1988, Alila et al. 1989, Meidan et al. 1990). On the
other hand, vascular endothelial cells secrete many
vasoactive substances that directly regulate P secretion
within the CL (Miyamoto et al. 1993, 1997a, 1997b,
Girsh et al. 1996a, 1996b, Hayashi et al. 2000, Milvae
2000, Skarzynski et al. 2000). Therefore, the vascular
components and blood flow within the CL have an
essential role in luteal function.
The CL of the bovine estrous cycle has a life span of
w17–18 days. It is universally accepted that pulsatile
release of prostaglandin F2a (PGF2a) from the endome-
trium initiates functional and structural regression of the
CL (McCracken et al. 1972, Silvia et al. 1991). As such,
PGF2a is regarded as a physiological luteolysin in the
cow. In general, the administration of PGF2a during the
mid-luteal phase (days 8–12 of the estrous cycle, mid-CL)
drastically reduces plasma P concentrations and the
volume of the CL. However, PGF2a does not induce
luteolysis during the early luteal phase (up to day 5 of the
estrous cycle; Henricks et al. 1974, Schallenberger et al.
1984). We have previously reported that treatment of
q 2008 Society for Reproduction and Fertility DOI: 10.1530/REP-07-0496
ISSN 1470–1626 (paper) 1741–7899 (online) Online version via www.reproduction-online.org
mature CL (day10 of the estrous cycle, referred to as mid-
CL), but not early CL, with a luteolytic dose of PGF2a
induced an acute increase (from 30 min to 2 h) in blood
flow at the periphery of the CL, which was followed by a
gradual decrease in luteal blood flow (Acosta et al. 2002).
Thus, PGF2a-induced increase in luteal blood flow is one
of the earliest physiological events observed during the
luteolytic cascade in the cow. However, the increase in
luteal blood flow might be a pharmacological response
induced by injection of exogenous PGF2a and physio-
logical impact of this phenomenon is not well known.
Recent studies suggest that the CL of the cow produces
many autocrine/paracrine factors that potentially
regulate vasodilation, vasoconstriction, angiogenesis,
and angiolysis (Miyamoto et al. 1993, 1997a, 1997b,
Girsh et al. 1996a, 1996b, Hayashi et al. 2000, Milvae
2000, Skarzynski et al. 2000). Endothelium-derived
nitric oxide (NO), a potent vasorelaxant, has been
suggested to be an important mediator of luteolysis in
the cow (Skarzynski et al. 2000, 2003, Korzekwa et al.
2004), rabbit (Boiti et al. 2003), rat (Motta et al. 1999,
2001), and human (Vega et al. 1998, 2000, Friden et al.
2000). The bovine CL has two types of NO synthase
(NOS), endothelial NOS (eNOS), and inducible NOS
(iNOS; Skarzynski et al. 2003). The eNOS binds to
calmodulin in a reversible and Ca2C-dependent manner
and releases NO for short periods (Moncada et al. 1991).
On the other hand, iNOS is calmodulin- and Ca2C-
independent (Sessa 1994). Treatment of bovine luteal
cells with agents that increase NO directly inhibits P
secretion (Skarzynski & Okuda 2000), and the inhibition
of ovarian NOS in vivo prolongs the duration of the
estrous cycle in the cow (Skarzynski et al. 2003).
Therefore, NO appears to be an important mediator of
the luteolytic cascade.
Endothelin-1 (EDN1), a vasoconstrictive peptide
(Yanagisawa et al. 1988), may also play a role in PGF2a-
induced luteolysis as well as spontaneous luteolysis in the
cow. EDN1 is produced by luteal endothelial cells, and
receptors for endothelin (EDNRA and EDNRB) are
expressed in the bovine CL (Girsh et al. 1996a, 1996b,
Berisha et al. 2000, 2002). PGF2a stimulates EDN1 mRNA
expression and the release of EDN1 in the bovine CL both
in vivo (Ohtani et al. 1998, Shirasuna et al. 2004a,
Watanabe et al. 2006) and in vitro (Girsh et al. 1996a,
1996b, Hinckley & Milvae 2001, Wright et al. 2001).
Importantly, EDN1 has been shown to inhibit P secretion
by cultured bovine luteal cells or luteal explants (Girsh et
al. 1996a, 1996b, Miyamoto et al. 1997a, 1997b,
Hinckley & Milvae 2001). These findings strongly suggest
that PGF2a together with EDN1 suppresses P and
decreases blood flow within the regressing CL (Shirasuna
et al. 2006, Watanabe et al. 2006).
In the present study, we aimed to clarify the role of
eNOS and NO in regulation of the increase in blood
flow observed at periphery of bovine CL during the
early stage of luteolysis using in vivo experimental
models. The series of experiments in the present study
were designed (1) to investigate and characterize the
changes in local blood flow with the expression of
eNOS, iNOS, and EDN1 mRNA during spontaneous
CL regression, (2) to determine the acute effects of
PGF2a administration on eNOS expression at the early
and mid-luteal phase (immature or early CL versus
mature or mid-CL) and the site (periphery versus
center) of the CL, and (3) to examine whether the
PGF2a-induced blood flow increase is mediated by NO
by determining whether the administration of an NO
donor or an NOS inhibitor affects the occurrence of
blood flow and luteolysis in the cow.
Results
Experiment 1: luteal blood flow and mRNA expression
during spontaneous luteolysis
We determined the changes in luteal blood flow together
with the changes in mRNA expression within the CL
during spontaneous luteolysis in the cow (Fig. 1). The
serum concentrations of P were maintained at high levels
from days 10 to 17 and rapidly decreased during
afternoon on day 18 (Fig. 1A). The serum concentrations
of estradiol 17 b (E) started to gradually increase during
afternoon on day 18 as plasma P decreased, and
remained elevated until estrus (Fig. 1A). The basal
volume of the CL on days 10–13 was 7.88G1.03 cm3
(meanGS.E.M., nZ8). The volume of the CL started to
decrease slowly on day 16, and further decreased until
the onset of estrus (Fig. 1A).
The luteal blood flow area was increased during
morning on day 14 (by about 40%, seven out of eight
cows), and on days 17–18 (by about 80%; Fig. 1B).
Thereafter, luteal blood flow area decreased to about
10–50% on days 19–21 of the estrous cycle (Fig. 1B). The
increase in luteal blood flow area on days 17–18 was
temporally associated with peaks in plasma PGFM. The
increase in blood flow on day 14 did not have a
corresponding peak in PGFM (Fig. 1B).
The expression of eNOS mRNA was greater on days
17–18 compared with on days 10–13 (Fig. 1C). The
expression of iNOS mRNA did not change during the
estrous cycle (Fig. 1C). The expression of EDN1 mRNA
was greater on days 17–18 and day 19 than on days
10–13 (Fig. 1C).
Experiment 2: luteal phase (early CL versus mid-CL)-
and site (periphery versus center of the CL)-dependent
effect of PGF2a
We investigated the localization of blood vessels and
microcapillary vessels in the periphery and center of the
CL using immunohistochemical detection of smooth
muscle actin (a marker of smooth muscle cells) and
von Willebrand factor (a marker of endothelial cells;
Figs 2–5). Morphological evidence revealed relatively
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large blood vessels (O20 mm) with smooth muscle layers
in the periphery of the mid-CL (Fig. 2). In the periphery
of the mid-CL, large blood vessels were detected
with immunoreactive staining for both vWF and SMA
in serial section. On the other hand, there was a little
evidence of large blood vessels with smooth muscle
layers in the center of the mid-CL (Fig. 2). In order to
make quantitative determinations blood vessels were
grouped into two types depending on their diameter,
large blood vessels (O20 mm) and microvascular vessels
(!20 mm) and the number of blood vessels was
determined as described in Materials and Methods. We
observed that the mid-CL contained more large blood
vessels in the periphery than did the early CL (Fig. 2C).
Although a few large blood vessels were observed in the
center of the mid-CL, none were observed in the center
of the early CL. No differences were noted in the
numbers of microvascular vessels in the peripheral and
center regions of early and mid-CL (Fig. 2D).
Immunostaining for eNOS is shown in Fig. 3. Although
eNOS immunostaining was technically very difficult and
Figure 1 Changes in plasma progesterone (P), plasma estradiol-17b (E),
corpus luteum (CL) volume, luteal blood flow area, plasma PGFM, eNOS
mRNA, iNOS mRNA, and EDN1 mRNA during spontaneous luteolysis.
(A) P concentrations are marked with a solid line, E concentrations are
marked with a dashed line, and CL volume is denoted with bars. (B) PGFM
concentrations are marked with a solid line, and luteal blood flow area is
denoted with bars. The gray area in (A) and (B) indicates time period of the
increase in luteal blood flow. (C) Black bars indicate eNOS mRNA
expression, white bars indicate iNOS mRNA expression, and gray bars
indicate EDN1 mRNA expression. The mean values of luteal blood flow
area and volume of CL during days 10–13 were used to calculate the
baseline for each measurement (defined as 100%) and all values were
expressed as a percentage of the corresponding baseline. For data analysis
on mRNA levels, the experimental period was divided into four time
periods (days 10–13, 14–16, 17–18, and 19) and the data during days
10–13 was used to calculate the baseline for each measurement (defined
as 100%). The mRNA levels for eNOS, iNOS, and EDN1were normalized
using b-actin mRNA and expressed as a percentage of this individual
baseline values. MeanGS.E.M. are presented, nZ5–8. The asterisk ( )
indicates values statistically different compared with baseline (P!0.05).
Figure 2 Localization of smooth muscle actin and von Willebrand
factor, and a number of large blood vessels and microvascular vessels in
the early and mid-CL. Immunohistochemistry was performed to detect
(A) smooth muscle actin (SMA) and (B) von Willebrand factor (vWF) in
luteal tissue sections. Areas within the CL were designated as the
periphery (in the range of 1 mm from the boundary between luteal
tissue and ovarian parenchyma) and the center of the CL (in the range of
1.5 mm from the center of the CL). Blood vessels were classified
depending on their diameter, large blood vessels as O20 mm and
microvascular vessels !20 mm. The number of blood of (C) large and
(D) microvascular vessels was determined as indicated in the Materials
and Methods. MeanGS.E.M. are presented, nZ4–5. Asterisk ( ) indicates
statistically different values (P!0.05).
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the expression of eNOS protein was low as described in
a previous study (Skarzynski et al. 2003), we observed
that eNOS protein was localized mainly in the
endothelial cells on blood vessels in the present study.
eNOS protein expression was localized to endothelial
cells of blood vessels and capillaries both in the early
and mid-CL. In saline-treated control animals, staining
for eNOS was observed in the periphery of the mid-CL
(Fig. 3E) and occasionally observed in the center of the
mid-CL (Fig. 3G). On the other hand, in PGF2a-treated
animals, greater staining for eNOS was observed in
the periphery (Fig. 3F) compared with the center
(Fig. 3H) of the mid-CL. Quantitative analysis of eNOS
immunostaining and mRNA expression is shown in
Fig. 4. In the early CL, PGF2a did not increase the eNOS
immunostaining area (Fig. 4A) or eNOS mRNA (Fig. 4B)
in the periphery and center of the CL. In contrast, PGF2a
administration significantly increased eNOS immunos-
taining and eNOS mRNA in the periphery, but not in the
center, of the mid-CL (Fig. 4C and D).
PGF2a receptor (FPr) immunostaining was localized to
luteal cells and blood vessels within the mid-CL (Fig. 5).
FPr immunostaining was present in some large blood
vessels, mainly in endothelial cells (Fig. 5A, C, E, and G;
indicated by arrows) in the peripheral region and some
small vessels in the center of the CL (Fig. 5B, D, and F;
indicated by gray arrowheads). Interestingly, vascular
interspace and vascular diameter clearly expanded in the
periphery (Fig. 5E and G; indicated by white arrowheads)
of the CL after PGF2a injection compared with the
periphery of the control CL (Fig. 5C).
Experiment 3: the effect of intraluteal injection of an
NO donor on day 14 of the estrous cycle
Injection of the NO donor S-nitroso-N-acetylpenicilla-
mine (SNAP) significantly increased blood flow in the
periphery of the CL (Fig. 6A). The increase in blood flow
was observed within 30 min of injection and was
Figure 3 Representative micrographs of eNOS immunostaining in the
early and mid-CL. The experiments were conducted on day 4 (early CL)
and on days 10–12 (mid-CL). Cows were either injected with PGF2a or
saline as control (early CL control, nZ5; early CL PGF2a treated, nZ5;
mid-CL control, nZ4; and mid-CL PGF2a treated, nZ4). At 30 min
after injection of PGF2a or saline, luteal blood flow was observed using
color Doppler ultrasound; and thereafter the cows were ovari-
ectomized and the CL were fixed for immunohistochemistry. Slides
were stained using a specific eNOS antibody as described in Materials
and Methods. Representative areas within the CL were designated as
the periphery and the center of the CL. White arrowheads indicate
eNOS immunostaining and gray arrowheads indicate eNOS immu-
nostaining on large blood vessels of the CL.
Figure 4 Image analysis of eNOS immunostaining and expression of
eNOS mRNA in the early and mid-CL. The experiments were conducted
on day 4 as early CL and days 10–12 as mid-CL, and PGF2a or saline as
control was injected respectively (early CL control, nZ5; early CL PGF2a
treated, nZ5; mid-CL control, nZ4; and mid-CL PGF2a treated, nZ4). At
30 min after injection of PGF2a or saline, luteal blood flow was observed
using color Doppler ultrasound. After observing, the cows were
ovariectomizedat 1 h after treatment, andportionsof the CLwerefixed for
immunohistochemistryandprocessed for mRNA analysis. Samplingareas
within the CL were designated as the periphery and the center of the CL.
(A and B) eNOS-positive staining area and eNOS mRNA expression in the
early CL. (C and D) eNOS-positive staining area and eNOS mRNA
expression in the mid-CL. White bar indicates control group, and black
bar indicates PGF2a-treated group in each figure. MeanGS.E.M. are
presented. Asterisk ( ) indicates statistically different values (P!0.05).
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maintained at high levels for up to 8 h, compared with
the control group (Fig. 6A). Color Doppler images of
blood flow in SNAP and vehicle injected CL are shown
in Fig. 6B and C respectively.
Plasma P concentrations decreased 60 h following the
NO donor injection (Fig. 6D). In the control group,
plasma P decreased at 120 h after vehicle injection
which corresponded to the increase in luteal blood flow
observed after 72–96 h (equivalent to days 17–18).
Compared with the vehicle-treated control group,
treatment with the NO donor also resulted in a more
rapid reduction in the volume of the CL (Fig. 6E). As a
result, the NO donor significantly shortened the estrous
cycle by about 3 days (17.5G0.6 days in the NO donor-
treated group versus 21.3G0.7 days in the control
group).
In the NO donor-treated group, plasma PGFM was
increased at 36 and 60 h after NO donor injection,
thereafter returned to basal levels (Fig. 6F). The changes
in PGFM were followed by decrease in plasma P
secretion (Fig. 6D). In the control group, plasma PGFM
increased at 96 h together with an increase in luteal
blood flow (Fig. 6A).
The expression of eNOS mRNA tended (P!0.1) to
increase at 4 and 12 h after treatment after NO donor
injection (Fig. 6G). On the other hand, EDN1 mRNA
expression increased within 12 h and remained elevated
for 72 h after NO donor injection (Fig. 6H).
Experiment 4: the effect of intraluteal injection of the
NOS inhibitor L-NAME on PGF2a-induced luteolysis
PGF2a administration induced an acute increase in luteal
blood flow in the control group (Fig. 7A). The injection of
the NOS inhibitor suppressed the acute increase in luteal
blood flow induced by PGF2a administration (Fig. 7A).
Images of luteal blood flow are shown in Fig. 7B and C.
In the control group, plasma P concentrations started to
decrease in the first hours after PGF2a administration,
however, in the NOS inhibitor group the PGF2a-induced
decline in plasma P was delayed by at least 8 h (Fig. 7D).
The volume of the CL was 6.43G0.43 cm3 in the control
group and 5.92G0.69 cm3 in the NOS inhibitor group.
In the control group, the CL volume started to decrease
4 h after PGF2a administration. Treatment with the NOS
inhibitor delayed the decrease in the CL volume by 8 h
(Fig. 7E). In the NOS inhibitor-treated group, CL volumes
were larger than in the control group throughout the
96-h period (Fig. 7E).
Discussion
The present study demonstrates that during spontaneous
CL regression in the cow an acute increase in luteal
blood flow in periphery of the mature CL is correlated
with pulsatile increase in plasma PGFM (a metabolite of
PGF2a produced by the uterus). We also demonstrate
that PGF2a acutely stimulates the expression of eNOS in
the periphery, but not in the center, of the mature CL.
Moreover, the administration of the NO donor SNAP
induced an acute increase in luteal blood flow and
Figure 5 Representative micrographs of FPr immunostaining in the mid-
CL. The experiments were conducted on days 10–12 as mid-CL, and
(A–E) saline or (F–H) PGF2a as control was injected respectively (mid-CL
control, nZ4 and mid-CL PGF2a treated, nZ4). At 30 min after injection
of PGF2a or saline, luteal blood flow was observed using color Doppler
ultrasound; and thereafter the cows were ovariectomized and portions of
the CL were fixed for immunohistochemistry. Large blood vessels in the
periphery of the CL are shown in (A), and capillary vessels in the center of
the CL in (B). The observation areas within the CL were designated as
(C, E and G) the periphery and (D and F) the center of the CL. (H) The
negative control of the CL. Black arrows indicate the FPr immunostaining
in vascular elements of large blood vessels, gray arrowheads indicate
capillary vessels, and white arrowheads indicate vasodilated blood
vessels following PGF2a injection in the periphery of the CL.
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shortened the estrous cycle. In contrast, injection of the
NOS inhibitor L-NAME completely suppressed the
increase in luteal blood flow and delayed the onset of
luteolysis in response to PGF2a administration. These
findings suggest that the acute increase in luteal blood
flow during luteolysis may be mediated by the local
action of NO on the arterioles in the periphery of the CL.
It is well known that the pulsatile release of PGF2a
from the uterus on days 17–18 of the estrous cycle
initiates luteolysis in the cow (Knickerbocker et al.
1988). In the present study, increase in luteal blood flow
in the periphery of the CL on days 17–18 correlated with
the peak levels of plasma PGFM, prior to the decline in
luteal P secretion (Fig. 1). These observations suggest that
pulsatile release of PGF2a from the uterus stimulates the
increase in luteal blood flow. A recent report by Ginther
et al. (2007) provided additional evidence showing that
CL blood flow increased with each PGFM pulse during
spontaneous luteolysis in the cow. In a previous study
using an electromagnetic flow transducer probe
surgically placed around the largest ovarian artery
ipsilateral to the CL, we demonstrated an acute increase
in blood flow volume into the ovary 30 min to 2 h after
PGF2a injection (Miyamoto et al. 1997a, 1997b). Taken
together, these observations indicate that the increase in
luteal blood flow is a common phenomenon in both
spontaneous and PGF2a-induced luteolysis in the cow.
NO is a potent vasorelaxant and appears to be a
good candidate to mediate the increase in luteal
blood flow. Previous studies have suggested that NO
may be an important mediator of luteolysis in the cow
(Skarzynski et al. 2000, 2003). Other studies in the rabbit
provide evidence for the existence a positive feedback
mechanism between PGF2a and NOS in the CL (Motta
et al. 1999). In the present study, we did not observe
changes in iNOS mRNA expression during the estrous
cycle. However, the expression of eNOS mRNA was
increased on days 17–18 coincident with the increase in
blood flow observed in the periphery of the CL during
natural CL regression. We also provided evidence for the
Figure 6 Effect of NO donor (SNAP) or control
(DMSO) treatment on plasma P, luteal blood
flow area, plasma PGFM, CL volume, luteal
blood flow images, eNOS mRNA, and EDN1
mRNA. The experiments were started on day 14
of the estrous cycle in the cow. The NO donor
(S-nitroso-N-acetylpenicillamine, SNAP;
10 mg/ml and 500 ml, nZ5) or dimethyl sulf-
oxide (DMSO) as control (nZ4) was injected
directly into the CL twice at 0 h (first injection)
and 4 h. (A) Change of luteal blood flow area.
(B and C) Typical image of luteal blood
flow treated by NO donor (SNAP) and DMSO.
(D–F) Change of plasma P concentration, CL
volume, and plasma PGFM concentration.
Control group is marked with a solid line and
NO donor-treated group is marked with a
dashed line (A and D–F). (G and H) The mRNA
expression of eNOS and EDN1; white bar
indicates control group, and black bar indicates
NO donor-treated group. The mean values of
luteal blood flow area, volume of CL and mRNA
expressions, the mean values of 0 h were used
to calculate the baseline for each measurement
(defined as 100%) and all values were
expressed as a percentage of the corresponding
baseline. MeanGS.E.M. are presented. Asterisk
( ) and sharp (#) indicate statistically different
values (P!0.05). Cross (C) indicates tendency
towards significant difference (P !0.1).
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presence of large blood vessels possessing smooth
muscle layers in the periphery of the CL, which should
be capable of regulating blood flow to the CL. In the
rabbit CL, the majority of large blood vessels with
smooth muscle layers also exist in the peripheral area,
but not in the central, of the CL (Wiltbank et al. 1990).
The results of this study provide morphological and
functional evidence for differential regulation of blood
flow in the periphery and center of the CL. Thus, we
suggested that the acute increase in luteal blood flow
occurs in the peripheral arterioles of the CL and this
phenomenon is induced by NO in response to uterine-
derived PGF2a.
Previous reports indicate that an injection of PGF2a
stimulated eNOS mRNA expression within the CL in the
sheep (Vonnahme et al. 2006) and in the rabbit (Boiti
et al. 2003). Moreover, plasma nitrite/nitrate concen-
trations increased immediately during the first 2 h after
an injection of PGF2a analog in the cow (Skarzynski et al.
2003). To extend these studies, we investigated the effect
of PGF2a on the early CL (resistant to PGF2a-induced
blood flow increases and luteolysis) and mid-CL
(sensitive to PGF2a). In addition, we analyzed the effect
of PGF2a on eNOS expression in the periphery and
center regions of the CL. Consistent with a lack of effect
of PGF2a on luteal blood flow in early CL, PGF2a did not
increase eNOS mRNA and immunostaining in the early
CL. In contrast, we observed that PGF2a acutely
stimulated the expression of eNOS mRNA and protein
in the periphery, but not in the center, of the mid-CL.
These results indicate that PGF2a stimulated eNOS
expression is correlated with the luteal blood flow
increase in periphery of the mid-CL. Thus, the present
study clearly shows that PGF2a has a site-restricted
action depending on not only luteal phase but also the
region in the CL. Indeed, we recently reported that to
mimic the local luteal region both of the periphery and
the center of the CL, we utilized co-cultures using
endothelial cells, smooth muscle cells and luteinized
granulosa cells (Shirasuna et al. 2008). Therefore, PGF2a
rapidly stimulated the expression of eNOS mRNA in
the periphery model (co-cultures of endothelial cells,
smooth muscle cells, and luteinized granulosa cells)
than in the center model (co-cultures of endothelial
cells and luteinized granulosa cells). Thus, the three-
dimensional structure of luteal tissue and cell–cell
interactions appears to be required for maximal
responsiveness to PGF2a.
The present series of experiments suggest that luteal
NO has multiple roles during luteolysis. First, we
observed that the administration of the NO donor
(SNAP) into the CL mimicked the actions of PGF2a on
the acute increase in luteal blood flow and expression of
EDN1 and eNOS mRNA. Also, direct injection of the
NO donor into the CL clearly reduced in plasma P and
CL volume resulting in a shortening of the estrous cycle.
Figure 7 Effect of the NOS inhibitor (L-NAME) or control (saline) treatment during PGF2a-induced luteolysis in the cow on plasma P, luteal blood flow
area, CL volume, and luteal blood flow images. NOS inhibitor (L-NAME, 50 mg/ml and 1 ml, nZ5) was directly injected into the CL four times at
K0.5 h, 0 h (PGF2a administration), 2 h, and 4 h together with PGF2a administration on day 14 of the estrous cycle in the cow (saline directly was
injected within the CL as control group, nZ5). (A) Change of luteal blood flow area. (B and C) Typical image of luteal blood flow treated by NOS
inhibitor (L-NAME) and saline as control. (D and E) Change of plasma P concentration and CL volume. Control group are marked with a solid line,
and NOS inhibitor-treated group are marked with a dashed line (A, D, and E). The mean values of luteal blood flow area and volume of CL, the mean
values of K0.5 h were used to calculate the baseline for each measurement (defined as 100%), and all values were expressed as a percentage of the
corresponding baseline. MeanGS.E.M. are presented. Asterisk ( ) and sharp (#) indicate statistically different values (P!0.05).
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In further support for a role for NO in luteal blood flow,
we found that the injection of the NOS inhibitor
(L-NAME) completely suppressed the acute increase in
luteal blood flow induced by PGF2a. Moreover, admin-
istration of the NOS inhibitor also delayed the decrease
in P secretion and CL volume. These findings strongly
suggest that NO has a potential to regulate luteal blood
flow and a luteal NO is a crucial factor to initiate
luteolysis due to induce a drastic increase in luteal blood
flow in the cow. Our results on functional (plasma P) and
structural regression (CL volume) are consistent with
previous reports that the NOS inhibitor L-NAME prevents
the occurrence of spontaneous and PGF2a-induced
luteolysis and extends the functional life of the CL in
the cow (Jaroszewski & Hansel 2000, Skarzynski et al.
2003). Furthermore, treatment of bovine luteal cells with
NO donors in vitro directly inhibits P secretion
(Skarzynski & Okuda 2000) and induces apoptosis as
observed by increased DNA fragmentation and
expression of FAS, BAX, and caspase-3 mRNA (Kor-
zekwa et al. 2006). The present series of experiments
indicate that luteal NO has multiple roles during
luteolysis that involve an increase in luteal blood flow,
functional luteolysis as observed by a decrease in P
secretion, and structural luteolysis as observed by a
reduction in luteal volume.
The present study provides the first evidence that
PGF2a exerts different effects on blood flow and gene
expression at the periphery and the center of the CL. The
actions of PGF2a are thought to be mediated by a plasma
membrane receptor termed FPr (Anderson et al. 2001),
although indirect actions of PGF2a cannot be ruled out
since our studies were conducted in a physiological
context in vivo. To determine the site of action of FPr,
immunohistochemistry was performed in sections of the
peripheral and central regions of the mature bovine CL.
As previously reported (Rao et al. 1979, Wiltbank et al.
1995), we observed that the steroidogenic luteal cells
express FPr. We also provide new evidence that FPr
staining is expressed in the larger blood vessels in the
peripheral region of the mature CL. Interestingly,
vascular interspace and vascular diameter expanded in
the periphery of the CL after PGF2a injection compared
with values obtained from saline-injected control
animals. This observation supports the idea that PGF2a
induces vasodilation in the periphery but not in the
center of the mature CL. There are conflicting reports on
the presence (Mamluk et al. 1998, Meidan et al. 2005) or
absence of FPr (Liptak et al. 2005) in bovine luteal
microvascular endothelial cells. The differences
observed in FPr may be due to the documented presence
of multiple endothelial cell types in the CL (Spanel-Bor-
owski 1991). However, based on our current results it
seems very likely that resistance blood vessels in the CL
also express FPr. Detailed analysis of FPr staining
patterns to specific cell types will require additional
investigation. It seems reasonable to propose that PGF2a
may act on blood vessels and luteal cells in the periphery
of the CL to stimulate the expression of eNOS and
vasodilation, thus inducing an acute increase in luteal
blood flow during the early stages of luteolysis. Future
studies will focus on the localization and function of FPr
in blood vessel types and their position within the CL.
There is a basic concept that shear stress is generated
when blood flow is increased (Lie et al. 1970). Shear
stress is the frictional tangential force imposed on the
vessel wall when blood flows through a vessel. Shear
stress modulates many physiological processes and is a
potent stimulation for NO production and vasodilation
(Davies 1995). In fact, NO production and expression of
eNOS mRNA and protein were elevated by shear stress
in a graded fashion in the ovine fetoplacental artery
endothelial cells (Li et al. 2003, 2004). The acute burst of
NO production may relate to an increase in eNOS
activity, probably via increase in intracellular Ca2C and
phosphorylation of eNOS (Li et al. 2004). Indeed, the
upregulation of eNOS mRNA by shear stress is
suppressed by Ca2C chelation in the bovine aorta
endothelial cells (Xiao et al. 1997). Moreover, PGF2a
acutely increases intracellular-free Ca2C in bovine luteal
cells (Davis et al. 1987). It is possible that luteolytic
pulses of PGF2a stimulate eNOS activity by inducing
intracellular Ca2C and simultaneously increasing luteal
blood flow/shear stress in periphery of the CL. Of interest
is a report that shear stress also rapidly upregulates EDN1
mRNA in human microvascular endothelial cells
(Morawietz et al. 2000), which could also increase
eNOS activity via increase in intracellular Ca2C. In the
present study, injection of the NO donor stimulated
EDN1 mRNA expression. Therefore, luteal blood flow
and shear stress generated by NO action may have the
potential to regulate luteolysis by stimulating EDN1,
another potential luteolytic mediator in the cow.
However, because of difficulty to experimentally control
luteal blood flow independent of NO action in vivo, the
exact evaluation of physiological impact of the blood
flow increase awaits further investigation.
In conclusion, the present study clearly shows that
PGF2a has a site-restricted action depending on not only
luteal phase but also the region in the CL. Our results
demonstrate that PGF2a stimulates eNOS expression,
vasodilation of blood vessels, and increased luteal blood
flow in the periphery of the mature CL. Furthermore,
pharmacologic studies indicate that the increased blood
flow is mediated by NO. Therefore, we suggest that the
acute increase in peripheral blood flow to the CL is one
of the first physiologic indicators of NO action in
response to PGF2a.
Materials and Methods
All experiments were conducted at the Field Center of Animal
Science and Agriculture, Obihiro University, and all the
experimental procedures complied with the Guidelines for
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the Care and Use of Agricultural Animals of Obihiro University.
Multiparous non-lactating Holstein cows were used for this
study; each had at least two estrous cycles of normal length
(21–23 days) before being used. Luteolysis was induced by i.m.
injection of 500 mg PGF2a analog (cloprostenol: Estrumate;
Takeda Co., Osaka, Japan); and 100 mg GnRH (Conceral;
Takeda Co.) were injected intramuscularly 48 h after the PGF2a
injection to ensure ovulation. The day of estrus was designated
as day 0.
Experiment 1: luteal blood flow and mRNA expression
of eNOS, iNOS, and EDN1 during spontaneous
luteolysis in the cow
In experiment 1, to investigate whether luteal blood flow
increases prior to starting luteolytic cascade during spon-
taneous luteolysis, we characterized the changes in local blood
flow together with the expression of eNOS, iNOS, and EDN1
mRNA in luteal tissue during spontaneous CL regression. Eight
multiparous non-lactating Holstein cows were used for this
study as described previously. The CL were examined by
transrectal ultrasonography using an ultrasound scanner (Aloka
SSD-5500; Mitaka, Tokyo, Japan) equipped with a 7.5 MHz
convex transducer. Ultrasonographic examinations of the CL
were carried out twice a day from day 10 of the estrous cycle
until the observation of next estrus. During each ultrasono-
graphic examination, the volume of CL and the blood flow area
within the CL were estimated as described previously (Acosta
et al. 2002). Areas of color represent regions with a flow
velocity higher than 2 mm/s. Simultaneous blood samples were
collected by caudal venipuncture for P, estradiol-17b (E), and
13,14-dihydro-15-keto-PGF2a (PGFM) measurements and
were immediately frozen at K30 8C until further analysis.
Tissue biopsy samples were obtained from five of the eight
cows in this study. Transvaginal ultrasound-guided biopsy
of the CL was conducted at four intervals: days 10–13, 14–16,
17–18 (after observation of increased luteal blood flow), and
19. Biopsies were performed as described by Tsai et al. (2001)
using an 18-guage biopsy needle (US Biopsy, Division of
Promex Inc., Indianapolis, IN, USA) mounted on an 18G
stainless steel needle guide attached to a 7.5 MHz transvaginal
convex transducer (UST-M15-21079; Aloka Co, Tokyo, Japan)
and an ultrasound scanner (SSD-5500, Aloka Co.). The biopsy
needle was inserted in to the needle channel of the transvaginal
probe and 3–5 mg CL tissue were collected. The CL tissue
sample was then immediately placed into a 1.5 ml micro-
centrifuge tube containing 0.4 ml TRIzol reagent (Gibco BRL),
immediately homogenized, and stored at K80 8C until being
analyzed.
Experiment 2: luteal phase (early CL versus mid-CL)-and
site (periphery versus center of the CL)-dependent
effects of PGF2a
We hypothesized that luteolytic PGF2a induces acute increase
in luteal blood flow in the periphery of the mature CL
stimulating NO production (eNOS stimulation), therefore, the
objective of experiment 2 was to determine the acute effects of
PGF2a administration on eNOS expression in the periphery and
center regions of the CL at the early and mid-luteal phases
(immature or early CL versus mature or mid-CL). Eighteen
multiparous non-lactating Holstein cows were used for this
study. The experiments were conducted on day 4 (early CL) and
on days 10–12 (mid-CL). Cows were either injected with
PGF2a or saline as control (early CL control, nZ5; early CL
PGF2a treated, nZ5; mid-CL control, nZ4; and mid-CL PGF2a
treated, nZ4). After 30 min of the injection of PGF2a or saline,
luteal blood flow was determined using color Doppler
ultrasound; and thereafter the cows were immediately
transvaginal ovariectomized as described previously (Berisha
et al. 2000). To examine the local effect of PGF2a in the CL,
tissue samples were collected from regions designated as the
periphery (in the range of 1 mm from boundary between luteal
tissue and ovarian parenchyma) and the center of the CL (in the
range of 1.5 mm from the center of the CL). Immediately after
collection, samples were placed into a 1.5 ml microcentrifuge
tube containing 0.4 ml TRIzol reagent, homogenized, and
stored at K80 8C until analysis. For immunohistochemistry, the
CL was enucleated from the ovary and dissected free of
connective tissue. Tissue samples from the periphery and
center of the CL were fixed in Bouin’s fixatives.
Experiment 3: effects of the NO donor SNAP on blood
flow and the life span of the CL during spontaneous
luteolysis
In experiment 3, we hypothesized that NO stimulated by PGF2a
increases luteal blood flow in the periphery of the CL,
therefore, we investigated the effect of NO on the luteal
blood flow during spontaneous luteolysis. Nine multiparous
non-lactating Holstein cows were used for this study. The
experiment was initiated on day 14 of the estrous cycle. The
NO donor (S-nitroso-N-acetylpenicillamine, SNAP; 10 mg/ml
and 500 ml, nZ5) or an identical amount of vehicle (dimethyl
sulfoxide, DMSO) as control (nZ4) was directly injected to the
CL at 0 h (first injection) and 4 h after the first injection. The
transvaginal injections to the CL were performed as described
in our previous study (Watanabe et al. 2006). To determine the
changes in mRNA expression within the CL, luteal mini-
biopsies were conducted at 0, 0.5, 4, 12, 24, 48, and 72 h after
the first injection as described previously (Watanabe et al.
2006). Ultrasonographic examinations and blood sampling
were carried out at 0, 0.5, 1, 2, 4, 6, 8, and 12 h; and thereafter
once a day until estrus. The CL tissue samples were
immediately placed into a 1.5 ml microcentrifuge tube
containing 0.4 ml TRIzol reagent, immediately homogenized,
and stored at K80 8C until being analyzed. Plasma samples
were immediately frozen at K30 8C until further analysis.
Experiment 4: the effect of NOS inhibitor L-NAME
on blood flow and the luteolytic cascade during
PGF2a-induced luteolysis
In experiment 4, to investigate whether PGF2a-induced acute
increase in luteal blood flow is occurred by mediating NOS–
NO system, we determined whether the administration of an
NOS inhibitor affected the occurrence of the acute increase in
luteal blood flow and CL regression during PGF2a-induced
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luteolysis. Ten multiparous non-lactating Holstein cows were
used for this study. An NOS inhibitor (L-NAME; 50 mg/ml and
1 ml, nZ5) was directly injected to the CL at K0.5 h prior to
PGF2a administration, concomitant with PGF2a administration
(time 0), and 2 and 4 h after PGF2a administration on day 14 of
the estrous cycle. The control group (nZ5) received saline
injections directly to the CL. Ultrasonographic examinations of
blood flow and CL size, and blood sampling were carried out at
K0.5, 0, 0.5, 1, 2, 4, 6, and 8 h following PGF2a treatment; and
thereafter once a day until estrus. Plasma samples were
immediately frozen at K30 8C until further analysis.
Hormone determination
After extraction, the concentrations of P, E, and PGFM in
plasma samples were determined in duplicate by second-
antibody enzyme immunoassays (EIAs) using 96-well ELISA
plates (NUNC-Immuno Plate, NUNC, Kampstrup, Denmark).
The extraction and EIA for P in plasma were performed as
described previously (Miyamoto et al. 1992). The recovery of P
from plasma was 85%. The standard curve ranged from 0.05 to
50 ng/ml, and the ED50 of assay was 2.4 ng/ml. The intra- and
inter-assay coefficients of variation (CVs) averaged 6.2 and
9.3% respectively.
The extraction and EIA for E in plasma were performed as
described previously Acosta et al. (2000). The recovery of E
from plasma was 85%. The standard curve ranged from 1.95 to
2000 pg/ml, and the ED50 of assay was 5.2 pg/ml. The intra-
and inter-assay CVs averaged 6.7 and 8.7% respectively.
The extraction and EIA for PGFM in plasma were performed
as described previously (Shirasuna et al. 2004b). The recovery
of PGFM from serum was 70%. The standard curve ranged
from 2.5 to 2500 pg/ml, and the ED50 of assay was 78 pg/ml.
The intra- and inter-assay CVs averaged 7.7 and 12.5%
respectively.
RNA extraction
Total RNA was extracted from CL biopsy samples following the
protocol of Chomczynski & Sacchi (1987) using TRIzol
reagent. The yield of extracted total luteal RNA for each
sample was determined by u.v. spectroscopy (optical density,
260 nm). The RNA concentration was measured using Bio-Tech
Photometer (WPA, Cambridge, UK) at 260 and 280 nm
absorbance. The extracted total RNA was stored in RNA
storage solution (Ambion, Austin, TX, USA) at K80 8C until
used for cDNA production.
cDNA production
RNA samples were treated with DNase using the RQ1 RNase-
free DNase kit (Promega Co). RNA (2 ml of 1 mg/ml) was
incubated for 30 min at 37 8C with 1 ml RQ1 RNase-free DNase
10! reaction buffer and 2 ml of 1 mg/ml RNase-free DNase.
Then, 1 ml RQ1 DNase stop solution (20 mM EGTA) was added
to terminate the reaction and incubated again for 10 min at
65 8C. First-strand cDNA synthesis was conducted according to
a commercial protocol described in SuperScript II Reverse
Transcriptase (Invitrogen Corp). The synthesized cDNA was
stored at K30 8C.
Real-time reverse transcription-PCR (real-time RT-PCR)
The levels of mRNA for eNOS, iNOS, EDN1, and b-actin were
quantified by real-time PCR with a LightCycler (Roche
Diagnostics Co.) using a commercial kit (LightCycler FastStart
DNA Master SYBR Green I; Roche Diagnostics Co). The
primers were designed using primer 3, based on bovine
sequences. The amplification program consisted of 15-min
activation at 95 8C followed by 40 cycles of PCR steps (15-s
denaturation at 94 8C, 30-s annealing at 58 8C, and a 20-s
extension at 72 8C). For the quantification of the target genes, a
series of standards were constructed by amplifying a fragment
of DNA (150–250 bp) that contains the target sequence for
real-time PCR. The primers used for real-time PCR were as
follows: eNOS (219 bp) forward 5 0-GGAAATCGGGGGTCTG-
GAGT-3 0 and reverse 5 0-TTGGCGAGCTGAAAGCTGTG-3 0;
iNOS (167 bp) forward 5 0-TCATCTTCGCCACCAAGCAG-3 0
and reverse 5 0-CAGTGATGGCCGACCTGATG-3 0; EDN1
(160 bp) forward 5 0-CAAATGCATCCTGCCTGGTC-3 0 and
reverse 5 0-ATTGCCACCCCCATAGAGGA-3 0; and b-actin
(256 bp) forward 5 0-CCAAGGCCAACCGTGAGAAAAT-3 0 and
reverse 5 0-CCACATTCCGTGAGGATCTTCA-3 0. The PCR
products were subjected to electrophoresis, and the target
band cut out and purified using a DNA purification kit;
SUPRECTM-01 (TaKaRa Bio. Inc., Otsu, Japan). Three to five
stepwise-diluted DNA standards were included in every PCR
run. The quantification of mRNA expression was done using
LightCycler Software (Version 3.5; Roche). Primer sets were
tested in luteal tissue samples to confirm amplification of single
bands, amplified products were cloned and sequenced to
confirm their identity, prior to use of primers in analysis of
samples. The values were normalized using b-actin as the
internal standard.
Immunohistochemistry
The ovaries were transported to the laboratory within 10 min
on ice immediately after surgical removal. The CL was
enucleated from the ovary and dissected free of connective
tissue. Tissue samples were fixed in Bouin’s fixatives for 24 h at
room temperature and then embedded in paraffin wax. Serial
sections (5 mm) were mounted on to APS-coated glass
microscope slides. The sections were stained with hematox-
ylin–eosin (H–E) for general histological observations.
Light microscopic immunohistochemical staining employing
the avidin–biotin peroxidase complex (ABC) method (Hsu et al.
1981) was used in the present study. The sections were
deparaffinized in xylene, rehydrated in graded series of
ethanol, and washed in distilled water (DW). Subsequently,
endogenous peroxidase was inactivated by treatment with
0.3% H2O2 in methanol for 10 min at room temperature. The
slides were then washed in 0.01 M PBS (pH 7.4). After
treatment with normal goat serum (2%) for 30 min at room
temperature, the sections were incubated with polyclonal
antibodies for von Willebrand factor (vWF; Dako, diluted
1:200), which is a marker of endothelial cells, smooth muscle
actin (SMA; Dako, M0851, diluted 1:200), eNOS (PA1-037,
diluted 1:50; Affinity BioReagents, Golden, CO, USA), and FPr
(Cat no. 101802, diluted 1:100; Cayman Chemical Corp.,
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Ann Arbor, MI, USA) overnight at 4 8C. As a negative control,
the sections were incubated with goat anti-rabbit IgG overnight
at 4 8C. After the incubation, the sections were washed in PBS,
incubated for 30 min at room temperature with biotinylated
goat anti-rabbit IgG (1:200, BA-1000; Vector Laboratories Inc;
Burlingame, CA, USA) for vWF, eNOS, FPr, and negative
control and with biotinylated goat anti-mouse IgG (1:200, BA-
9200, Vector Laboratories Inc.) for SMA, and then washed in
PBS. Horseradish peroxidase (HRP)-conjugated ABC (1:2, PK-
6100, Vectastain Elite ABC kit; Vector Laboratories Inc.)
combined with secondary antibody was applied to tissue slides
at room temperature for 30 min. The binding sites were
visualized with 0.02% 3,3 0-diaminobebzidine tetrahydrochlor-
ide (DAB) in 50 mM Tris–HCl (pH 7.4) containing 0.02%
H2O2. After immunohistochemical staining, the sections were
lightly counterstained with Mayer’s hematoxylin. The sections
were washed in DW, dehydrated in graded series of ethanol,
and cleared in xylene and coverslipped.
Quantification methods
Number of blood vessels
The number of blood vessels was determined by counting the
number of SMA-positive vessels per unit area in the histological
section at 200! as described in a previous study (Sugino et al.
2005). Due to the regional variations in size, blood vessels
were grouped depending on their diameter, one group
consisted of large blood vessels (O20 mm) and another group
consisted of microvascular vessels (!20 mm). Histological
sections were obtained from three animals in each group. The
number of blood vessels in each group was determined by
counting three randomly chosen areas both at the periphery
and the center of the CL. Quantification was performed
independently by three observers. Average values obtained
from each tissue section were used to determine the meansG
S.E.M. from multiple sections from different animals. The results
were expressed as number meansGS.E.M. per unit area.
Percentage area of eNOS immunostaining
The positive staining areas were extracted using PopImaging
(Version 3.01; Digital Being Kids, Yokohama, Japan) to
calculate the percentage area of the immunostaining (area of
the immunostaining divided by the total area measured!100)
as described previously (Al-zi’abi et al. 2003). Areas were
analyzed at 200! magnification using one section from each
animal and five fields per section. The results were expressed as
percentage meansGS.E.M. per unit area (early CL control, nZ5;
early CL PGF2a treated, nZ5; mid-CL control, nZ4; and
mid-CL PGF2a treated, nZ4).
Statistical analysis
All data are presented as meansGS.E.M. In experiment 1, for
data analysis the mean values of luteal blood flow area and
volume of CL during days 10–13 were used to calculate the
baseline for each measurement (defined as 100%), and all
values are expressed as a percentage of the corresponding
baseline. For data analysis on mRNA levels in experiment 1, the
experimental period was divided into four periods (days 10–13,
14–16, 17–18, and 19), and the data during days 10–13 were
used to calculate the baseline for each measurement (defined
as 100%). The mRNA levels for each ligand were normalized
using b-actin mRNA (ratio of ligand:b-actin) and expressed as
a percentage of this individual baseline values. In experiment
2, the positive areas of eNOS staining were presented as a
percentage of total area. The number of blood vessels was
determined by counting, and the results were expressed as
number meansGS.E.M. per unit area. In experiments 3 and 4,
the mean values of luteal blood flow area and volume of
CL at 0 h (experiment 3) or K0.5 h (experiment 4) were
used to calculate the baseline for each measurement (defined
as 100%), and all values were expressed as a percentage
of the corresponding baseline. The statistical significance of
differences was assessed by one-way ANOVA followed by
Bonferroni’s multiple comparison test. Probabilities !5%
(P!0.05) were considered significant.
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